PubMed:32496122
Annnotations
LitCovid-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 52-60 | SP_7 | denotes | COVID-19 |
T2 | 104-120 | CHEBI:50846 | denotes | immunomodulators |
T3 | 104-120 | CHEBI:50846 | denotes | immunomodulators |
T4 | 136-141 | CHEBI:23888 | denotes | drugs |
T5 | 136-141 | CHEBI:23888 | denotes | drugs |
T6 | 168-178 | SP_7 | denotes | SARS-CoV-2 |
T7 | 320-329 | CL:0002627 | denotes | activated |
T8 | 330-342 | CL:0000094 | denotes | granulocytes |
T9 | 347-356 | CL:0000576 | denotes | monocytes |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 330-342 | Body_part | denotes | granulocytes | http://purl.org/sig/ont/fma/fma62854 |
T2 | 347-356 | Body_part | denotes | monocytes | http://purl.org/sig/ont/fma/fma62864 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 28-46 | Disease | denotes | ulcerative colitis | http://purl.obolibrary.org/obo/MONDO_0005101|http://purl.obolibrary.org/obo/MONDO_0009960 |
T3 | 28-38 | Disease | denotes | ulcerative | http://purl.obolibrary.org/obo/MONDO_0043839 |
T4 | 39-46 | Disease | denotes | colitis | http://purl.obolibrary.org/obo/MONDO_0005292 |
T5 | 52-60 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T6 | 145-163 | Disease | denotes | ulcerative colitis | http://purl.obolibrary.org/obo/MONDO_0005101|http://purl.obolibrary.org/obo/MONDO_0009960 |
T8 | 145-155 | Disease | denotes | ulcerative | http://purl.obolibrary.org/obo/MONDO_0043839 |
T9 | 156-163 | Disease | denotes | colitis | http://purl.obolibrary.org/obo/MONDO_0005292 |
T10 | 168-176 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T11 | 179-188 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T12 | 239-257 | Disease | denotes | ulcerative colitis | http://purl.obolibrary.org/obo/MONDO_0005101|http://purl.obolibrary.org/obo/MONDO_0009960 |
T14 | 239-249 | Disease | denotes | ulcerative | http://purl.obolibrary.org/obo/MONDO_0043839 |
T15 | 250-257 | Disease | denotes | colitis | http://purl.obolibrary.org/obo/MONDO_0005292 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 219-220 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T2 | 320-329 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activated |
T3 | 347-356 | http://purl.obolibrary.org/obo/CL_0000576 | denotes | monocytes |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 104-120 | Chemical | denotes | immunomodulators | http://purl.obolibrary.org/obo/CHEBI_50846 |
T2 | 136-141 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 28-46 | Phenotype | denotes | ulcerative colitis | http://purl.obolibrary.org/obo/HP_0100279 |
T2 | 145-163 | Phenotype | denotes | ulcerative colitis | http://purl.obolibrary.org/obo/HP_0100279 |
T3 | 239-257 | Phenotype | denotes | ulcerative colitis | http://purl.obolibrary.org/obo/HP_0100279 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
3 | 14-23 | Chemical | denotes | Adacolumn | |
4 | 28-46 | Disease | denotes | ulcerative colitis | MESH:D003093 |
5 | 52-60 | Disease | denotes | COVID-19 | MESH:C000657245 |
9 | 145-163 | Disease | denotes | ulcerative colitis | MESH:D003093 |
10 | 168-188 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
11 | 239-257 | Disease | denotes | ulcerative colitis | MESH:D003093 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-61 | Sentence | denotes | The effect of Adacolumn® on ulcerative colitis with COVID-19. |
T2 | 62-189 | Sentence | denotes | Crespo et al. comment on the influence of immunomodulators and biological drugs on ulcerative colitis and SARS-CoV-2 infection. |
T3 | 190-402 | Sentence | denotes | Granulo-monocytoapheresis is a treatment used in ulcerative colitis outbreaks, whose mechanism of action is to selectively retain activated granulocytes and monocytes, in order to reduce the inflammatory process. |